Commercial Strategy & Fractional Leadership
De-risking biopharma assets from diligence to launch. I mitigate commercial failure points in Asset Valuation, New Product Planning, Go-to-Market Strategy, and Launch Planning; ensuring your investment survives the transition from clinical data to commercial reality.
My Services
From Due Diligence and early-stage strategy to launch execution, I jump in where you need me most; so you can stay focused on leading and not chasing deliverables.
New Product Planning & Commercial Strategy
I help define the commercial path for your clinical assets. I provide the critical commercial input needed for Stage Gating and Portfolio Reviews, bridging clinical development with commercial reality.
I plan and execute cross-functional launches that deliver. I design campaigns and field-force strategy, and activate customer engagement, so every detail is ready on the launch day.
Launch Planning & Execution
I validate commercial viability. I bridge the gap between clinical data and market reality to determine if an asset is actually reimbursable, adoptable, and scalable in today’s and tomorrow’s markets.
Due Diligence and Asset Evaluation